News

ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update

ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento

ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Thermogenesis Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules

ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies

ThermoGenesis Regains Compliance with Nasdaq Minimum Bid Price Requirement

ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2022 and Provides Corporate Update

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2022 and Provide a Corporate Strategic Update

ThermoGenesis Closes $2.05 Million Public Offering

ThermoGenesis Prices $2.05 Million Public Offering

H.C. Wainwright 24th Annual Global Investment Conference (2022)

ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Thermogenesis Holdings to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2021, and Provides Corporate Update

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2021 and Provide a Corporate Strategic Update

ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2021 and Provides Corporate Update

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2021 and Provide a Corporate Strategic Update

ThermoGenesis Holdings Announces 2020 Year End Financial Results and Provides Corporate Update
